Changes in STIL and SAS6 levels have been linked to several subtypes of breast cancer, such as TNBC (232, 233), luminal breast cancer (234, 235), and HER2-positive breast cancer (236, 237). This evidence concerns the gene ERBB2 and breast carcinoma.